Northstar is committed to producing
novel strategies for sepsis care and bioterrorism countermeasure. Our proprietary Fab-DT antibody paradigm drives innovation.
We are a small business with big ideas -
like developing
antibodies for the bedside and the frontline
Fab-DT confronts biological agents
at the point of incident:
whether at the bedside or on the battlefield.
Northstar seeks to protect our patients,
troops and civilians against
sepsis, antimicrobial resistance
and bioagent terrorism.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.